1. Home
  2. VOC vs ICCM Comparison

VOC vs ICCM Comparison

Compare VOC & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VOC

VOC Energy Trust Units of Beneficial Interest

N/A

Current Price

$3.36

Market Cap

49.0M

Sector

Energy

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.61

Market Cap

43.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VOC
ICCM
Founded
2010
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
49.0M
43.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
VOC
ICCM
Price
$3.36
$0.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
129.9K
150.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
11.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.87
Revenue Next Year
N/A
$31.38
P/E Ratio
$6.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$0.54
52 Week High
$3.74
$1.53

Technical Indicators

Market Signals
Indicator
VOC
ICCM
Relative Strength Index (RSI) 58.81 49.55
Support Level $2.73 $0.59
Resistance Level $3.48 $0.62
Average True Range (ATR) 0.20 0.04
MACD 0.04 0.01
Stochastic Oscillator 51.70 45.31

Price Performance

Historical Comparison
VOC
ICCM

About VOC VOC Energy Trust Units of Beneficial Interest

VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: